MNIV.F Stock Overview

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia. More details

MNIV.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	0/6
Financial Health	4/6
Dividends	2/6

Rewards

Trading at 77.1% below our estimate of its fair value

Earnings are forecast to grow 46.14% per year

Risk Analysis

Dividend of 7.54% is not well covered by earnings or free cash flows

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Monash IVF Group Limited Competitors

Joint

NasdaqCM:JYNT

US$160.8m

Oncology Institute

NasdaqCM:TOI

US$212.1m

Sonida Senior Living

NYSE:SNDA

US$432.4m

Community Health Systems

NYSE:CYH

US$378.5m

Price History & Performance

Summary of share price highs, lows and changes for Monash IVF Group
Historical stock prices
Current Share Price	AU$0.74
52 Week High	AU$0.74
52 Week Low	AU$0.74
Beta	1.03
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	MNIV.F	US Healthcare	US Market
7D	0%	-0.4%	2.2%
1Y	n/a	-9.6%	8.2%

Return vs Industry: Insufficient data to determine how MNIV.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how MNIV.F performed against the US Market.

Price Volatility

Is MNIV.F's price volatile compared to industry and market?
MNIV.F volatility
MNIV.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.7%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	4.1%

Stable Share Price: MNIV.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MNIV.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	997	Michael Knaap	www.monashivfgroup.com.au

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services.

Monash IVF Group Limited Fundamentals Summary

How do Monash IVF Group's earnings and revenue compare to its market cap?
MNIV.F fundamental statistics
Market cap	US$169.13m
Earnings (TTM)	-US$1.44m
Revenue (TTM)	US$169.72m

1.0x

P/S Ratio

-117.5x

P/E Ratio

Is MNIV.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MNIV.F income statement (TTM)
Revenue	AU$269.79m
Cost of Revenue	AU$180.09m
Gross Profit	AU$89.71m
Other Expenses	AU$91.99m
Earnings	-AU$2.29m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 22, 2025

Earnings per share (EPS)	-0.0059
Gross Margin	33.25%
Net Profit Margin	-0.85%
Debt/Equity Ratio	31.2%

How did MNIV.F perform over the long term?

See historical performance and comparison

Dividends

7.5%

Current Dividend Yield

-903%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/12 21:22
End of Day Share Price	2025/01/14 00:00
Earnings	2024/12/31
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Monash IVF Group Limited is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tara Speranza	Bell Potter
Martyn Jacobs	Bell Potter
David Stanton	CLSA

Monash IVF Group OTCPK:MNIV.F Stock Report